MedPath

Prone Breast Irradiation for Pendulous Breasts

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Device: Mamma board
Registration Number
NCT00181363
Lead Sponsor
Maastricht Radiation Oncology
Brief Summary

We hypothesize that for large pendulous breasts, breast irradiation in supine and prone position are equivalent with regard to coverage of the PTV, but with a better dose homogeneity in prone position and a smaller radiation exposure of lung and heart.The purpose of this study is to compare the 3-D dose distribution in PTV(Planning Target Volume) and normal tissues in prone position versus supine position.

Detailed Description

Local excision followed by adjuvant radiotherapy has become standard treatment for women with early-stage breast cancer. Adjuvant radiotherapy may encounter technical difficulties in patients with pendulous breasts when treated in supine position.

Based upon literature and our own preliminary experiences, we hypothesize that for large pendulous breasts, breast irradiation in supine and prone position are equivalent with regard to coverage of the PTV, but with a better dose homogeneity in prone position and a smaller radiation exposure of lung and heart. However, no quantitative data are yet available to test this hypothesis. Therefore, the aim of our study is to compare the 3-D dose distribution in PTV and normal tissues in prone position versus supine position. For treatment in prone-position an in-house developed device, the "mammaboard" was used.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • Patients should have had breast-conserving surgery for breast cancer or DCIS (Ductal Carcinoma in Situ)
  • No indication for radiotherapy of regional nodes
  • Large, pendulous breasts (bra size D and over)
Exclusion Criteria
  • Regional radiotherapy is indicated
  • Unable to lie in prone position

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mamma boardMamma boarduse of the mamma board during radiotherapy
Primary Outcome Measures
NameTimeMethod
Dose Homogeneity 1: PTV1 day after treatment planning

Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) and normal tissues in prone position versus supine position

Dose Homogeneity 3: V95 %1 day after treatment planning

PTV coverage (% of PTV \< 95% of prescribed dose) in prone position versus supine position

Dose Homogeneity 2: V105% and V107%1 day after treatment planning

Quantitatively compare the 3 D dose distribution in the PTV (Planning Target Volume) in prone position versus supine position

Secondary Outcome Measures
NameTimeMethod
PTV Coverage in Organs at Risk: Heart V30during treatment planning

Doses in organs at risk: heart V30: the volumes (%) of the heart that received \>= 30Gy

PTV Coverage in Organs at Risk: MLD (Gy)during treatment planning

Doses in organs at risk: lung MLD (Mean Lung Dose)

Trial Locations

Locations (1)

Maastricht Radiation Oncology

🇳🇱

Heerlen, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath